St. Jude Children's Research Hospital
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1962-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.stjude.org/
Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor
Phase 2
Completed
- Conditions
- First Posted Date
- 2003-05-08
- Last Posted Date
- 2011-10-04
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 53
- Registration Number
- NCT00004068
- Locations
- 🇺🇸
Saint Jude Children's Research Hospital, Memphis, Tennessee, United States
Oxaliplatin in Treating Children With Advanced Solid Tumors
Phase 1
Completed
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2012-10-23
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 26
- Registration Number
- NCT00005844
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2017-04-26
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 12
- Registration Number
- NCT00004005
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
© Copyright 2024. All Rights Reserved by MedPath